1
|
Kashapov RR, Razuvayeva YS, Ziganshina AY, Mukhitova RK, Sapunova AS, Voloshina AD, Nizameev IR, Kadirov MK, Zakharova LY. Design of N-Methyl-d-Glucamine-Based Resorcin[4]arene Nanoparticles for Enhanced Apoptosis Effects. Mol Pharm 2020; 17:40-49. [PMID: 31746611 DOI: 10.1021/acs.molpharmaceut.9b00599] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The addition of specific chemical groups in a macrocycle structure influences its functional properties and, consequently, can provide new possibilities, among which are aggregation properties, water solubility, biocompatibility, stimuli response, biological activity, etc. Herein, we report synthesis of new resorcin[4]arene with N-methyl-d-glucamine groups on the upper rim and n-decyl chains on the lower rim, an investigation of its self-assembly behavior in aqueous media, and its use as a building block for the formation of drug nanocontainer. N-methyl-d-glucamine fragments in the resorcin[4]arene structure promote higher stability in solutions, simplification of self-aggregation, and increased biological activity. Antimicrobial and hemolytic activity assessment revealed that this resorcin[4]arene obtained is nontoxic. The study of cell penetration was carried out with both free and encapsulated doxorubicin (DOX). Surprisingly, DOX-loaded macrocycle aggregates are more efficient in causing apoptosis in human cancer cell line. Conceivably, this knowledge will help in the rational design of DOX combination for novel drug-administration strategies in cancer treatment.
Collapse
Affiliation(s)
- Ruslan R Kashapov
- Arbuzov Institute of Organic and Physical Chemistry , FRC Kazan Scientific Center of RAS , 8 Arbuzov str. , Kazan 420088 , Russia
| | - Yuliya S Razuvayeva
- Arbuzov Institute of Organic and Physical Chemistry , FRC Kazan Scientific Center of RAS , 8 Arbuzov str. , Kazan 420088 , Russia.,Kazan National Research Technological University , 68 K. Marx str. , Kazan 420015 , Russia
| | - Albina Y Ziganshina
- Arbuzov Institute of Organic and Physical Chemistry , FRC Kazan Scientific Center of RAS , 8 Arbuzov str. , Kazan 420088 , Russia
| | - Rezeda K Mukhitova
- Arbuzov Institute of Organic and Physical Chemistry , FRC Kazan Scientific Center of RAS , 8 Arbuzov str. , Kazan 420088 , Russia
| | - Anastasiya S Sapunova
- Arbuzov Institute of Organic and Physical Chemistry , FRC Kazan Scientific Center of RAS , 8 Arbuzov str. , Kazan 420088 , Russia
| | - Alexandra D Voloshina
- Arbuzov Institute of Organic and Physical Chemistry , FRC Kazan Scientific Center of RAS , 8 Arbuzov str. , Kazan 420088 , Russia
| | - Irek R Nizameev
- Arbuzov Institute of Organic and Physical Chemistry , FRC Kazan Scientific Center of RAS , 8 Arbuzov str. , Kazan 420088 , Russia.,Kazan National Research Technological University , 68 K. Marx str. , Kazan 420015 , Russia
| | - Marsil K Kadirov
- Arbuzov Institute of Organic and Physical Chemistry , FRC Kazan Scientific Center of RAS , 8 Arbuzov str. , Kazan 420088 , Russia.,Kazan National Research Technological University , 68 K. Marx str. , Kazan 420015 , Russia
| | - Lucia Ya Zakharova
- Arbuzov Institute of Organic and Physical Chemistry , FRC Kazan Scientific Center of RAS , 8 Arbuzov str. , Kazan 420088 , Russia.,Kazan National Research Technological University , 68 K. Marx str. , Kazan 420015 , Russia
| |
Collapse
|
2
|
Salonen J, Mäkilä E. Thermally Carbonized Porous Silicon and Its Recent Applications. ADVANCED MATERIALS (DEERFIELD BEACH, FLA.) 2018; 30:e1703819. [PMID: 29484727 DOI: 10.1002/adma.201703819] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/09/2017] [Revised: 09/08/2017] [Indexed: 06/08/2023]
Abstract
Recent progress in research on thermally carbonized porous silicon (TCPSi) and its applications is reported. Despite a slow start, thermal carbonization has now started to gain interest mainly due to new emerging areas for applications. These new areas, such as optical sensing, drug delivery, and energy storage, require stable surface chemistry and physical properties. TCPSi is known to have all of these desired properties. Herein, the above-listed properties of TCPSi are summarized, and the carbonization processes, functionalization, and characterization of TCPSi are reviewed. Moreover, some of the emerging fields of TCPSi applications are discussed and recent advances in the fields are introduced.
Collapse
Affiliation(s)
- Jarno Salonen
- Industrial Physics Laboratory, Department of Physics and Astronomy, University of Turku, FI-20014, Turku, Finland
| | - Ermei Mäkilä
- Industrial Physics Laboratory, Department of Physics and Astronomy, University of Turku, FI-20014, Turku, Finland
| |
Collapse
|
3
|
Cheah HY, Kiew LV, Lee HB, Japundžić-Žigon N, Vicent MJ, Hoe SZ, Chung LY. Preclinical safety assessments of nano-sized constructs on cardiovascular system toxicity: A case for telemetry. J Appl Toxicol 2017; 37:1268-1285. [DOI: 10.1002/jat.3437] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2016] [Revised: 12/14/2016] [Accepted: 12/14/2016] [Indexed: 12/19/2022]
Affiliation(s)
- Hoay Yan Cheah
- Department of Pharmacology, Faculty of Medicine; University of Malaya; 50603 Kuala Lumpur Malaysia
| | - Lik Voon Kiew
- Department of Pharmacology, Faculty of Medicine; University of Malaya; 50603 Kuala Lumpur Malaysia
| | - Hong Boon Lee
- Department of Pharmacy, Faculty of Medicine; University of Malaya; 50603 Kuala Lumpur Malaysia
| | - Nina Japundžić-Žigon
- Institute of Pharmacology, Clinical Pharmacology and Toxicology, School of Medicine; University of Belgrade; Republic of Serbia
| | - Marίa J. Vicent
- Polymer Therapeutics Lab; Centro de Investigación Príncipe Felipe; Av. Eduardo Primo Yúfera 3 E-46012 Valencia Spain
| | - See Ziau Hoe
- Department of Physiology, Faculty of Medicine; University of Malaya; 50603 Kuala Lumpur Malaysia
| | - Lip Yong Chung
- Department of Pharmacy, Faculty of Medicine; University of Malaya; 50603 Kuala Lumpur Malaysia
| |
Collapse
|
4
|
Disulphide cross linked pullulan based cationic polymer for improved gene delivery and efflux pump inhibition. Colloids Surf B Biointerfaces 2016; 146:879-87. [DOI: 10.1016/j.colsurfb.2016.07.013] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2016] [Revised: 06/18/2016] [Accepted: 07/04/2016] [Indexed: 11/17/2022]
|
5
|
Vlasova M, Smirin BV. Personalized Approach in Nanomedicine. ADVANCES IN MEDICAL TECHNOLOGIES AND CLINICAL PRACTICE 2016. [DOI: 10.4018/978-1-5225-0754-3.ch001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
This chapter characterizes need for new patient-specific approaches in medicine. The authors here illustrate role of nanomedicine and particularly nanotheranostics, combining diagnostic and therapeutic functions, in the paradigm of personalized disease treatment. This chapter discusses current insights regarding the mechanisms of nano-bio interactions and the origin of adverse effects of nanoformulations. Furthermore, this chapter illustrates possible reasons behind an individual physiological response to a given nanomedicine, such as type and stage of disease, physiological conditions and lifestyle of a patient. Finally, a review of possible approaches for the initial choice of nanoformulation, suitable for a given patient is provided at the end of the chapter.
Collapse
|
6
|
Tomuleasa C, Braicu C, Irimie A, Craciun L, Berindan-Neagoe I. Nanopharmacology in translational hematology and oncology. Int J Nanomedicine 2014; 9:3465-79. [PMID: 25092977 PMCID: PMC4113407 DOI: 10.2147/ijn.s60488] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Nanoparticles have displayed considerable promise for safely delivering therapeutic agents with miscellaneous therapeutic properties. Current progress in nanotechnology has put forward, in the last few years, several therapeutic strategies that could be integrated into clinical use by using constructs for molecular diagnosis, disease detection, cytostatic drug delivery, and nanoscale immunotherapy. In the hope of bringing the concept of nanopharmacology toward a viable and feasible clinical reality in a cancer center, the present report attempts to present the grounds for the use of cell-free nanoscale structures for molecular therapy in experimental hematology and oncology.
Collapse
Affiliation(s)
- Ciprian Tomuleasa
- Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania ; Department of Hematology, Ion Chiricuta Cancer Center, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
| | - Cornelia Braicu
- Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
| | - Alexandra Irimie
- Department of Prosthetic Dentistry and Dental Materials, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
| | - Lucian Craciun
- Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
| | - Ioana Berindan-Neagoe
- Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania ; Department of Immunology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania ; Department of Functional Genomics and Experimental Pathology, the Oncological Institute "Prof Dr Ion Chiricuta", Cluj-Napoca, Romania
| |
Collapse
|